MedPath

CHIANG MAI UNIVERSITY

CHIANG MAI UNIVERSITY logo
🇹🇭Thailand
Ownership
Private
Established
1964-01-01
Employees
501
Market Cap
-
Website
http://www.cmu.ac.th

Clinical Trials

137

Active:6
Completed:69

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:5
Phase 2:11
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (107 trials with phase data)• Click on a phase to view related trials

Not Applicable
52 (48.6%)
Phase 4
22 (20.6%)
Phase 3
16 (15.0%)
Phase 2
11 (10.3%)
Phase 1
5 (4.7%)
Early Phase 1
1 (0.9%)

Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents

Not yet recruiting
Conditions
Hepatitis A
Hepatitis A Virus
Vaccine-Preventable Diseases
First Posted Date
2025-06-24
Last Posted Date
2025-06-24
Lead Sponsor
Chiang Mai University
Target Recruit Count
60
Registration Number
NCT07032610
Locations
🇹🇭

Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV

Phase 3
Recruiting
Conditions
Hepatitis A
Hepatitis A Virus
Vaccine-Preventable Diseases
Interventions
Biological: Inactivated hepatitis A vaccine (I-HAV)
First Posted Date
2025-05-18
Last Posted Date
2025-06-17
Lead Sponsor
Chiang Mai University
Target Recruit Count
36
Registration Number
NCT06978621
Locations
🇹🇭

Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Preoperative Anemia Affected to Postoperative Outcomes in Liver Resection

Not yet recruiting
Conditions
Liver Resection
Anemia
Postoperative Mortality and Morbidity
First Posted Date
2025-04-01
Last Posted Date
2025-04-01
Lead Sponsor
Chiang Mai University
Target Recruit Count
728
Registration Number
NCT06905041

Theobromine from Cocoa and Cardiovascular Risk Factors

Not Applicable
Recruiting
Conditions
Hypertension
First Posted Date
2025-02-11
Last Posted Date
2025-02-11
Lead Sponsor
Chiang Mai University
Target Recruit Count
42
Registration Number
NCT06820944
Locations
🇹🇭

Research Institute for Health Sciences, Chiang Mai University, Mueang, Chiang Mai, Thailand

The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study

Early Phase 1
Conditions
Hemorrhoid
Interventions
First Posted Date
2024-12-24
Last Posted Date
2024-12-24
Lead Sponsor
Chiang Mai University
Target Recruit Count
120
Registration Number
NCT06748014
Locations
🇹🇭

Chiangmai university, Chiangmai, Maung, Thailand

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.